Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 5.26% | 140.92 | 0.0% | $1089.53m | |
| AMGN | Amgen, Inc. | 0.84% | 248.95 | 1.3% | $709.58m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -2.18% | 8.51 | 0.7% | $594.88m | |
| NVAX | Novavax, Inc. | 1.97% | 179.74 | 80.0% | $528.85m | |
| ILMN | Illumina, Inc. | -0.09% | 403.37 | 3.5% | $527.61m | |
| GILD | Gilead Sciences, Inc. | 0.14% | 65.11 | 1.0% | $506.15m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.25% | 475.17 | 2.7% | $424.91m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.46% | 213.35 | 1.9% | $365.10m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.35% | 155.01 | 2.0% | $327.81m | |
| BIIB | Biogen, Inc. | 0.92% | 268.17 | 1.7% | $308.69m | |
| EXAS | EXACT Sciences Corp. | -2.30% | 125.54 | 18.4% | $188.77m | |
| OCGN | Ocugen, Inc. | 0.72% | 6.96 | 0.0% | $185.95m | |
| BNTX | BioNTech SE | 6.68% | 122.14 | 0.0% | $183.14m | |
| CRSP | CRISPR Therapeutics AG | -3.85% | 115.74 | 0.6% | $172.12m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.71% | 93.35 | 4.9% | $170.52m |
Company Profile
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.